Cargando…

Real Time Monitoring of Inhibition of Adipogenesis and Angiogenesis by (−)-Epigallocatechin-3-Gallate in 3T3-L1 Adipocytes and Human Umbilical Vein Endothelial Cells

Little is known about the effect of (−)-epigallocatechin-3-gallate (EGCG) on angiogenesis in adipocytes. We aimed to test the effect of EGCG on the expression of vascular endothelial growth factor (VEGF) in adipocytes. The levels of VEGF secretion, the expression of VEGF message ribonucleic acid (mR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Wenjing, Song, Huanlei, Cai, Wei, Shen, Xiuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632457/ https://www.ncbi.nlm.nih.gov/pubmed/26516907 http://dx.doi.org/10.3390/nu7105437

Ejemplares similares

Effects of Epigallocatechin-3-Gallate on Autophagic Lipolysis in Adipocytes
por: Kim, Sang-Nam, et al.
Publicado: (2017)

Epigallocatechin-3-gallate Regulates Inducible Nitric Oxide Synthase Expression in Human Umbilical Vein Endothelial Cells
por: Ahn, Hee Yul, et al.
Publicado: (2011)

Effect of nano-encapsulated (-) epigallocatechin gallate on triglyceride accumulation in 3T3-L1 adipocytes
por: Bapat, Priyanka, et al.
Publicado: (2012)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

(-)-Epigallocatechin-3-Gallate Inhibits eNOS Uncoupling and Alleviates High Glucose-Induced Dysfunction and Apoptosis of Human Umbilical Vein Endothelial Cells by PI3K/AKT/eNOS Pathway
por: Zhang, Zhiyong, et al.
Publicado: (2020)

Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition
por: Kim, Sejin, et al.
Publicado: (2023)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
por: Zhang, Lingyun, et al.
Publicado: (2019)

Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
por: Min, Kyoung-jin, et al.
Publicado: (2014)

Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
por: Cheong, Yucheol, et al.
Publicado: (2021)

(-)-Epigallocatechin-3-Gallate Inhibits eNOS Uncoupling and Alleviates High Glucose-Induced Dysfunction and Apoptosis of Human Umbilical Vein Endothelial Cells by PI3K/AKT/eNOS Pathway [Corrigendum]
Publicado: (2020)

Antioxidant and Cytoprotective Effects of (−)-Epigallocatechin-3-(3″-O-methyl) Gallate
por: Kim, Eunji, et al.
Publicado: (2019)

(−)‑Epigallocatechin‑3‑O‑gallate upregulates the expression levels of miR‑6757‑3p, a suppressor of fibrosis‑related gene expression, in extracellular vesicles derived from human umbilical vein endothelial cells
por: Murata, Motoki, et al.
Publicado: (2023)

Epigallocatechine-3-gallate Inhibits the Adipogenesis of Human Mesenchymal Stem Cells via the Regulation of Protein Phosphatase-2A and Myosin Phosphatase
por: Bécsi, Bálint, et al.
Publicado: (2022)

(−)-Epigallocatechin-3-gallate induces secretion of anorexigenic gut hormones
por: Song, Won-Young, et al.
Publicado: (2015)

Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2016)

Effects of epigallocatechin-3-gallate on bovine oocytes matured in vitro
por: Huang, Ziqiang, et al.
Publicado: (2018)

Dietary Copper Reduces the Hepatotoxicity of (−)-Epigallocatechin-3-Gallate in Mice
por: Kaleri, Najeeb Ahmed, et al.
Publicado: (2017)

Epigallocatechin-3-Gallate Reduces Fat Accumulation in Caenorhabditis elegans
por: Liu, Jinning, et al.
Publicado: (2018)

Epigallocatechin-3-gallate counters cisplatin toxicity of rat testes
por: Fouad, Amr A., et al.
Publicado: (2017)

Green Tea Extracts Epigallocatechin-3-gallate for Different Treatments
por: Chu, Chenyu, et al.
Publicado: (2017)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
por: Tang, L., et al.
Publicado: (2017)

Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1
por: Li, Xiaoguang, et al.
Publicado: (2017)

In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
por: Wang, Wang, et al.
Publicado: (2019)

Effects of artificial honey and epigallocatechin-3-gallate on streptococcus pyogenes
por: Jiang, Xiaoge, et al.
Publicado: (2022)

Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs
por: Wang, Chunguang, et al.
Publicado: (2023)

RNA-seq profiling of white and brown adipocyte differentiation treated with epigallocatechin gallate
por: Zhang, Pengpeng, et al.
Publicado: (2022)

Combination curcumin and (−)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway
por: Jin, G, et al.
Publicado: (2017)

Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells
por: Mirzaaghaei, Somaye, et al.
Publicado: (2019)

Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise
por: Ahmed, Salahuddin
Publicado: (2010)

Enhancement of Cisplatin Sensitivity in Human Cervical Cancer: Epigallocatechin-3-Gallate
por: Kilic, Ulkan, et al.
Publicado: (2015)

Effect of epigallocatechin-3-gallate application for remaining carious dentin disinfection
por: de Assis, Jorgiana Silva, et al.
Publicado: (2015)

(−)-Epigallocatechin-3-Gallate Decreases Osteoclastogenesis via Modulation of RANKL and Osteoprotegrin
por: Chen, Shih-Tse, et al.
Publicado: (2019)

The regulation of steroid receptors by epigallocatechin-3-gallate in breast cancer cells
por: Hallman, Kelly, et al.
Publicado: (2017)

Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors
por: Liu, Changwei, et al.
Publicado: (2019)

Dipeptidyl Peptidase-4 Is a Target Protein of Epigallocatechin-3-Gallate
por: Hou, Huimin, et al.
Publicado: (2020)

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
por: Marín, Víctor, et al.
Publicado: (2023)

Dual action of epigallocatechin-3-gallate in virus-induced cell Injury
por: Mostafa, Ahmed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gjdo8vkd0n5v6vkfo69vh8ici9